AiRWA Reveals Acquisition of $30 Million in Solana Tokens
Investment in AiRWA: AiRWA received approximately $30 million in Solana tokens, enhancing its financial foundation and focusing on integrating Solana as a core asset for trading pairs.
Tokenized U.S. Equities: AiRWA Exchange has completed test runs for trading tokenized U.S. equities, allowing users to trade digital representations of U.S. stocks with the ease and speed of cryptocurrencies on the blockchain.
Trade with 70% Backtested Accuracy
Analyst Views on YYAI
About YYAI
About the author

- Earnings Beat: Ericsson's Q4 earnings of $0.27 per share exceeded analyst expectations of $0.23, indicating strong performance in a competitive telecom market, which is likely to boost investor confidence.
- Sales Growth: The company reported quarterly sales of $7.367 billion, surpassing the analyst consensus of $7.030 billion, reflecting sustained demand in the 5G and network infrastructure sectors, potentially driving future revenue growth.
- Stock Surge: Ericsson shares jumped 7.1% to $10.26 in pre-market trading, reflecting a positive market reaction to its earnings report, which may attract more investor interest.
- Optimistic Market Outlook: With increasing global demand for 5G technology, Ericsson's earnings growth could provide funding for future strategic expansions, further solidifying its leadership position in the industry.

- Bioavailability Improvement: Gelteq Ltd's oral gel delivery platform achieved over a 22% increase in bioavailability compared to an FDA-approved oil-based product in preclinical trials, indicating significant technological advantages that could enhance market acceptance and drive future sales growth.
- Stock Surge: Following this positive announcement, Gelteq's shares surged 50.1% in pre-market trading to $1.25, reflecting strong investor confidence in the new technology and its market potential.
- Enhanced Market Competitiveness: By improving product bioavailability, Gelteq not only meets the growing consumer demand but also positions itself more favorably in the competitive pharmaceutical market, potentially driving the company's long-term strategic development.
- Increased Investor Interest: With Gelteq's technological advancements and stock price increase, market attention on its future performance has significantly risen, likely attracting more investors and partners, thereby facilitating the company's capital operations and business expansion.

- Director Share Purchase: Director Hongyu Zhou purchased 1.1 million shares at prices of $1.23 and $1.41 over Sunday and Monday, increasing his total holdings to 1.6 million shares, indicating strong confidence in the company's future prospects.
- Strong Stock Surge: Airwa's stock soared nearly 16% in after-hours trading on Tuesday, reflecting positive market reactions to the insider purchase, with the stock already up over 60% this year, showcasing robust investor interest.
- Retail Investor Attention: Following its pivot to cryptocurrency last year, Airwa has emerged as a retail favorite, with a 205% increase in Stocktwits watchers over the past 12 months, indicating market approval of its new strategic direction.
- Market Sentiment Shift: As of late Tuesday, the retail sentiment for YYAI rose to 84/100, entering the 'extremely bullish' zone, reflecting optimistic expectations for the company's future performance, especially after its joint venture with JuCoin Capital.

- Financing Scale: AiRWA Inc. successfully sold 15,382,378 shares of common stock at $1.02 each through a registered direct offering, raising approximately $15.69 million, which enhances the company's liquidity for future growth initiatives.
- Use of Proceeds: The funds raised will be utilized for advancing a previously announced joint venture, potential corporate acquisitions, and general working capital, indicating the company's strategic intent for future expansion despite no specific acquisition plans currently.
- Underwriter Role: A.G.P./Alliance Global Partners acted as the sole placement agent for this offering, ensuring the smooth execution of the transaction and providing professional market support to the company.
- Compliance Statement: This offering is conducted under an effective S-3 registration statement, ensuring compliance and providing transparent disclosures to investors, thereby enhancing market confidence.

- Financing Scale: AiRWA Inc. has entered into securities purchase agreements to sell 15,382,378 shares at $1.02 each, raising approximately $15.69 million, which will provide essential funding for the company's future initiatives.
- Use of Proceeds: The net proceeds from this offering will be allocated towards advancing a previously announced joint venture, potential corporate acquisitions, and general working capital, indicating the company's strategic intent for future growth despite lacking specific acquisition plans.
- Underwriter Role: A.G.P./Alliance Global Partners is acting as the sole placement agent for this offering, ensuring a professional and compliant financing process that enhances investor confidence in AiRWA's operations.
- Registration Statement Background: This offering is conducted under an effective shelf registration statement on Form S-3 that became effective on June 11, 2025, ensuring the legality and transparency of the issuance, thereby increasing market trust in AiRWA.
Securities Purchase Agreement: AiRWA (YYAI) has entered into agreements to sell 15.38 million shares at a price of $1.02 per share in a registered direct offering.
Financial Proceeds: The offering is expected to generate approximately $15.69 million in gross proceeds before fees and expenses, with the transaction anticipated to close around December 22, 2025.
Use of Proceeds: The funds raised will be utilized to advance a joint venture, explore potential corporate acquisitions, and support working capital and general corporate purposes.
Market Reaction: Following the announcement, YYAI shares experienced a decline of 2.2% in premarket trading on Friday.







